Cargando…
Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury
BACKGROUND: Despite recent improvements in angioplasty and placement of drug‐eluting stents in treatment of atherosclerosis, restenosis and in‐stent thrombosis impede treatment efficacy and cause numerous deaths. Research efforts are needed to identify new molecular targets for blocking restenosis....
Autores principales: | Yao, Yufeng, Hu, Zhenkun, Ye, Jian, Hu, Changqing, Song, Qixue, Da, Xingwen, Yu, Yubin, Li, Hui, Xu, Chengqi, Chen, Qiuyun, Wang, Qing Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669188/ https://www.ncbi.nlm.nih.gov/pubmed/28649088 http://dx.doi.org/10.1161/JAHA.117.005889 |
Ejemplares similares
-
Angiogenic Factor AGGF1 Activates Autophagy with an Essential Role in Therapeutic Angiogenesis for Heart Disease
por: Lu, Qiulun, et al.
Publicado: (2016) -
Angiogenic Factor with G-patch and FHA Domain 1 (AGGF1) Expression in Human Vascular Lesions
por: Zhan, Maosheng, et al.
Publicado: (2016) -
Angiogenic factor AGGF1 blocks neointimal formation after vascular injury via interaction with integrin α7 on vascular smooth muscle cells
por: Yu, Yubing, et al.
Publicado: (2022) -
High Expression of Angiogenic Factor with G-Patch and FHA Domain1 (AGGF1) Predicts Poor Prognosis in Gastric Cancer
por: Yao, Han-Hui, et al.
Publicado: (2017) -
Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1
por: He, Zuhan, et al.
Publicado: (2023)